1
|
Martins FCOL, Pimenta LC, De Souza D. Antidepressants determination using an electroanalytical approach: A review of methods. J Pharm Biomed Anal 2021; 206:114365. [PMID: 34555633 DOI: 10.1016/j.jpba.2021.114365] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2021] [Revised: 09/02/2021] [Accepted: 09/04/2021] [Indexed: 01/07/2023]
Abstract
Antidepressants are the pharmaceutical compounds used in the treatment of depression, anxiety disorders and all related disturbances promoted by genetic factors, environmental problems or modern lifestyles. Nonetheless, the inadequate ingestion of antidepressants provokes adverse effects in the human body and can contaminate the environment. For this reason, it is necessary to identify and quantify these compounds in biological fluids, natural water, wastewater, and pharmaceutical formulations. Consequently, this review presents the main electroanalytical techniques used in the analysis of antidepressants, indicating the advantages, which include low cost, suitable analytical parameters, simplified sample preparation steps, easy operation and reduced time for completion of the analysis. Reports in specialized literature, published from 2000 to 2020, are presented and some are discussed, demonstrating that the electroanalytical techniques can be employed, with success, in the determination of antidepressants, indicating alternative methodologies to improve analytical parameters and minimize the use and generation of toxic residues.
Collapse
Affiliation(s)
- Fernanda C O L Martins
- Green Analytical Chemistry Group (GEQAV), College of Agriculture "Luiz de Queiroz", São Paulo University, PO Box 9, Piracicaba, SP 13418-970, Brazil
| | - Laura C Pimenta
- Laboratory of Electroanalytical Applied to Biotechnology and Food Engineering (LEABE), Chemistry Institute, Uberlândia Federal University, Major Jerônimo street, 566, Patos de Minas, MG 38700-002, Brazil
| | - Djenaine De Souza
- Laboratory of Electroanalytical Applied to Biotechnology and Food Engineering (LEABE), Chemistry Institute, Uberlândia Federal University, Major Jerônimo street, 566, Patos de Minas, MG 38700-002, Brazil.
| |
Collapse
|
2
|
Patriarchi T, Cho JR, Merten K, Marley A, Broussard GJ, Liang R, Williams J, Nimmerjahn A, von Zastrow M, Gradinaru V, Tian L. Imaging neuromodulators with high spatiotemporal resolution using genetically encoded indicators. Nat Protoc 2019; 14:3471-3505. [PMID: 31732722 DOI: 10.1038/s41596-019-0239-2] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Accepted: 08/20/2019] [Indexed: 12/28/2022]
Abstract
Multiple aspects of neural activity, from neuronal firing to neuromodulator release and signaling, underlie brain function and ultimately shape animal behavior. The recently developed and constantly growing toolbox of genetically encoded sensors for neural activity, including calcium, voltage, neurotransmitter and neuromodulator sensors, allows precise measurement of these signaling events with high spatial and temporal resolution. Here, we describe the engineering, characterization and application of our recently developed dLight1, a suite of genetically encoded dopamine (DA) sensors based on human inert DA receptors. dLight1 offers high molecular specificity, requisite affinity and kinetics and great sensitivity for measuring DA release in vivo. The detailed workflow described in this protocol can be used to systematically characterize and validate dLight1 in increasingly intact biological systems, from cultured cells to acute brain slices to behaving mice. For tool developers, we focus on characterizing five distinct properties of dLight1: dynamic range, affinity, molecular specificity, kinetics and interaction with endogenous signaling; for end users, we provide comprehensive step-by-step instructions for how to leverage fiber photometry and two-photon imaging to measure dLight1 transients in vivo. The instructions provided in this protocol are designed to help laboratory personnel with a broad range of experience (at the graduate or post-graduate level) to develop and utilize novel neuromodulator sensors in vivo, by using dLight1 as a benchmark.
Collapse
Affiliation(s)
- Tommaso Patriarchi
- Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA.,Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland
| | - Jounhong Ryan Cho
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA
| | - Katharina Merten
- Waitt Advanced Biophotonics Center, Salk Institute for Biological Studies, La Jolla, CA, USA
| | - Aaron Marley
- Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA
| | - Gerard Joey Broussard
- Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA.,Princeton Neuroscience Institute and Department of Molecular Biology, Princeton University, Princeton, NJ, USA
| | - Ruqiang Liang
- Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA
| | - John Williams
- Vollum Institute, Oregon Health & Science University, Portland, OR, USA.
| | - Axel Nimmerjahn
- Waitt Advanced Biophotonics Center, Salk Institute for Biological Studies, La Jolla, CA, USA.
| | - Mark von Zastrow
- Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA, USA.
| | - Viviana Gradinaru
- Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
| | - Lin Tian
- Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, CA, USA.
| |
Collapse
|
3
|
Noga BR, Turkson RP, Xie S, Taberner A, Pinzon A, Hentall ID. Monoamine Release in the Cat Lumbar Spinal Cord during Fictive Locomotion Evoked by the Mesencephalic Locomotor Region. Front Neural Circuits 2017; 11:59. [PMID: 28912689 PMCID: PMC5582069 DOI: 10.3389/fncir.2017.00059] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2017] [Accepted: 08/09/2017] [Indexed: 01/28/2023] Open
Abstract
Spinal cord neurons active during locomotion are innervated by descending axons that release the monoamines serotonin (5-HT) and norepinephrine (NE) and these neurons express monoaminergic receptor subtypes implicated in the control of locomotion. The timing, level and spinal locations of release of these two substances during centrally-generated locomotor activity should therefore be critical to this control. These variables were measured in real time by fast-cyclic voltammetry in the decerebrate cat's lumbar spinal cord during fictive locomotion, which was evoked by electrical stimulation of the mesencephalic locomotor region (MLR) and registered as integrated activity in bilateral peripheral nerves to hindlimb muscles. Monoamine release was observed in dorsal horn (DH), intermediate zone/ventral horn (IZ/VH) and adjacent white matter (WM) during evoked locomotion. Extracellular peak levels (all sites) increased above baseline by 138 ± 232.5 nM and 35.6 ± 94.4 nM (mean ± SD) for NE and 5-HT, respectively. For both substances, release usually began prior to the onset of locomotion typically earliest in the IZ/VH and peaks were positively correlated with net activity in peripheral nerves. Monoamine levels gradually returned to baseline levels or below at the end of stimulation in most trials. Monoamine oxidase and uptake inhibitors increased the release magnitude, time-to-peak (TTP) and decline-to-baseline. These results demonstrate that spinal monoamine release is modulated on a timescale of seconds, in tandem with centrally-generated locomotion and indicate that MLR-evoked locomotor activity involves concurrent activation of descending monoaminergic and reticulospinal pathways. These gradual changes in space and time of monoamine concentrations high enough to strongly activate various receptors subtypes on locomotor activated neurons further suggest that during MLR-evoked locomotion, monoamine action is, in part, mediated by extrasynaptic neurotransmission in the spinal cord.
Collapse
Affiliation(s)
- Brian R Noga
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| | - Riza P Turkson
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| | - Songtao Xie
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| | - Annette Taberner
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| | - Alberto Pinzon
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| | - Ian D Hentall
- The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami Miller School of MedicineMiami, FL, United States
| |
Collapse
|
4
|
McCall JG, Siuda ER, Bhatti DL, Lawson LA, McElligott ZA, Stuber GD, Bruchas MR. Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior. eLife 2017; 6. [PMID: 28708061 PMCID: PMC5550275 DOI: 10.7554/elife.18247] [Citation(s) in RCA: 168] [Impact Index Per Article: 24.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2016] [Accepted: 07/13/2017] [Indexed: 01/01/2023] Open
Abstract
Increased tonic activity of locus coeruleus noradrenergic (LC-NE) neurons induces anxiety-like and aversive behavior. While some information is known about the afferent circuitry that endogenously drives this neural activity and behavior, the downstream receptors and anatomical projections that mediate these acute risk aversive behavioral states via the LC-NE system remain unresolved. Here we use a combination of retrograde tracing, fast-scan cyclic voltammetry, electrophysiology, and in vivo optogenetics with localized pharmacology to identify neural substrates downstream of increased tonic LC-NE activity in mice. We demonstrate that photostimulation of LC-NE fibers in the BLA evokes norepinephrine release in the basolateral amygdala (BLA), alters BLA neuronal activity, conditions aversion, and increases anxiety-like behavior. Additionally, we report that β-adrenergic receptors mediate the anxiety-like phenotype of increased NE release in the BLA. These studies begin to illustrate how the complex efferent system of the LC-NE system selectively mediates behavior through distinct receptor and projection-selective mechanisms. DOI:http://dx.doi.org/10.7554/eLife.18247.001
Collapse
Affiliation(s)
- Jordan G McCall
- Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St. Louis, United States.,Washington University Pain Center, Washington University School of Medicine, St. Louis, United States.,Department of Neuroscience, Washington University School of Medicine, St. Louis, United States.,Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, United States
| | - Edward R Siuda
- Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St. Louis, United States.,Washington University Pain Center, Washington University School of Medicine, St. Louis, United States.,Department of Neuroscience, Washington University School of Medicine, St. Louis, United States.,Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, United States
| | - Dionnet L Bhatti
- Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St. Louis, United States.,Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, United States
| | - Lamley A Lawson
- Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St. Louis, United States
| | - Zoe A McElligott
- Department of Psychiatry, University of North Carolina, Chapel Hill, United States.,Bowles Center for Alcohol Studies, University of North Carolina, Chapel Hill, United States
| | - Garret D Stuber
- Department of Psychiatry, University of North Carolina, Chapel Hill, United States.,Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, United States.,Neuroscience Center, University of North Carolina, Chapel Hill, United States
| | - Michael R Bruchas
- Department of Anesthesiology, Division of Basic Research, Washington University School of Medicine, St. Louis, United States.,Washington University Pain Center, Washington University School of Medicine, St. Louis, United States.,Department of Neuroscience, Washington University School of Medicine, St. Louis, United States.,Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, United States.,Department of Biomedical Engineering, Washington University, St. Louis, United States
| |
Collapse
|
5
|
Nguyen MD, Venton BJ. Fast-scan Cyclic Voltammetry for the Characterization of Rapid Adenosine Release. Comput Struct Biotechnol J 2014; 13:47-54. [PMID: 26900429 PMCID: PMC4720017 DOI: 10.1016/j.csbj.2014.12.006] [Citation(s) in RCA: 58] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2014] [Revised: 12/19/2014] [Accepted: 12/23/2014] [Indexed: 12/20/2022] Open
Abstract
Adenosine is a signaling molecule and downstream product of ATP that acts as a neuromodulator. Adenosine regulates physiological processes, such as neurotransmission and blood flow, on a time scale of minutes to hours. Recent developments in electrochemical techniques, including fast-scan cyclic voltammetry (FSCV), have allowed direct detection of adenosine with sub-second temporal resolution. FSCV studies have revealed a novel mode of rapid signaling that lasts only a few seconds. This rapid release of adenosine can be evoked by electrical or mechanical stimulations or it can be observed spontaneously without stimulation. Adenosine signaling on this time scale is activity dependent; however, the mode of release is not fully understood. Rapid adenosine release modulates oxygen levels and evoked dopamine release, indicating that adenosine may have a rapid modulatory role. In this review, we outline how FSCV can be used to detect adenosine release, compare FSCV with other techniques used to measure adenosine, and present an overview of adenosine signaling that has been characterized using FSCV. These studies point to a rapid mode of adenosine modulation, whose mechanism and function will continue to be characterized in the future.
Collapse
Affiliation(s)
- Michael D Nguyen
- Department of Chemistry, University of Virginia, McCormick Road, PO BOX 400319, Charlottesville, VA 22904, United States
| | - B Jill Venton
- Department of Chemistry, University of Virginia, McCormick Road, PO BOX 400319, Charlottesville, VA 22904, United States
| |
Collapse
|
6
|
The timing of dopamine- and noradrenaline-mediated transmission reflects underlying differences in the extent of spillover and pooling. J Neurosci 2014; 34:7645-56. [PMID: 24872568 DOI: 10.1523/jneurosci.0166-14.2014] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Metabotropic transmission typically occurs through the spillover activation of extrasynaptic receptors. This study examined the mechanisms underlying somatodendritic dopamine and noradrenaline transmission and found that the extent of spillover and pooling varied dramatically between these two transmitters. In the mouse ventral tegmental area, the time course of D2-receptor-mediated IPSCs (D2-IPSCs) was consistent between cells and was unaffected by altering stimulation intensity, probability of release, or the extent of diffusion. Blocking dopamine reuptake with cocaine extended the time course of D2-IPSCs and suggested that transporters strongly limited spillover. As a result, individual release sites contributed independently to the duration of D2-IPSCs. In contrast, increasing the release of noradrenaline in the rat locus ceruleus prolonged the duration of α2-receptor-mediated IPSCs even when reuptake was intact. Spillover and subsequent pooling of noradrenaline activated distal α2-receptors, which prolonged the duration of α2-IPSCs when multiple release sites were activated synchronously. By using the rapid application of agonists onto large macropatches, we determined the concentration profile of agonists underlying the two IPSCs. Incorporating the results into a model simulating extracellular diffusion predicted that the functional range of noradrenaline diffusion was nearly fivefold greater in the locus ceruleus than dopamine in the midbrain. This study demonstrates that catecholamine synapses differentially regulate the extent of spillover and pooling to control the timing of local inhibition and suggests diversity in the roles of uptake and diffusion in governing metabotropic transmission.
Collapse
|
7
|
Hamazaki T, Hamazaki K. Fish oils and aggression or hostility. Prog Lipid Res 2008; 47:221-32. [DOI: 10.1016/j.plipres.2008.02.001] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2008] [Revised: 02/11/2008] [Accepted: 02/22/2008] [Indexed: 10/22/2022]
|
8
|
Huang HP, Wang SR, Yao W, Zhang C, Zhou Y, Chen XW, Zhang B, Xiong W, Wang LY, Zheng LH, Landry M, Hökfelt T, Xu ZQD, Zhou Z. Long latency of evoked quantal transmitter release from somata of locus coeruleus neurons in rat pontine slices. Proc Natl Acad Sci U S A 2007; 104:1401-6. [PMID: 17227848 PMCID: PMC1783087 DOI: 10.1073/pnas.0608897104] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The locus coeruleus (LC) harbors a compact group of noradrenergic cell bodies projecting to virtually all parts of the central nervous system. By using combined measurements of amperometry and patch-clamp, quantal vesicle release of noradrenaline (NA) was detected as amperometric spikes, after depolarization of the LC neurons. After a pulse depolarization, the average latency of amperometric spikes was 1,870 ms, whereas the latency of glutamate-mediated excitatory postsynaptic currents was 1.6 ms. A substantial fraction of the depolarization-induced amperometric spikes originated from the somata. In contrast to glutamate-mediated excitatory postsynaptic currents, NA secretion was strongly modulated by the action potential frequency (0.5-50 Hz). Somatodendritic NA release from LC upon enhanced cell activity produced autoinhibition of firing and of NA release. We conclude that, in contrast to classic synaptic transmission, quantal NA release from LC somata is characterized by a number of distinct properties, including long latency and high sensitivity to action potential frequency.
Collapse
Affiliation(s)
- H.-P. Huang
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - S.-R. Wang
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - W. Yao
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - C. Zhang
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - Y. Zhou
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - X.-W. Chen
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - B. Zhang
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - W. Xiong
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - L.-Y. Wang
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - L.-H. Zheng
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
| | - M. Landry
- Institut National de la Santé et de la Recherche Médicale E358, Institut Francois Magendie, Universite Victor Segalen Bordeaux 2, 33077 Bordeaux, France
| | - T. Hökfelt
- Department of Neuroscience, Karolinska Institutet, S-171 71 Stockholm, Sweden; and
- To whom correspondence may be addressed. E-mail:
or
| | - Z.-Q. D. Xu
- Department of Neuroscience, Karolinska Institutet, S-171 71 Stockholm, Sweden; and
| | - Z. Zhou
- *Institute of Neuroscience, Shanghai Institutes for the Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
- Institute of Molecular Medicine, Peking University, Beijing 100871, China
- State Key Laboratory of Biomembrane Engineering, College of Life Sciences, Peking University, Beijing 100871, China
- To whom correspondence may be addressed. E-mail:
or
| |
Collapse
|
9
|
John CE, Jones SR. Exocytotic release of dopamine in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice. Neurochem Int 2006; 49:737-45. [PMID: 16901588 DOI: 10.1016/j.neuint.2006.06.004] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2006] [Revised: 06/08/2006] [Accepted: 06/23/2006] [Indexed: 11/23/2022]
Abstract
The present study used voltammetry to ascertain whether electrically stimulated somatodendritic dopamine release in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice was due to exocytosis or dopamine transporter reversal, as has been debated. The maximal concentration of electrically evoked dopamine release was similar between ventral tegmental area slices from dopamine transporter knockout and C57BL/6 mice. Dopamine transporter blockade (10 microM nomifensine) in slices from C57BL/6 mice inhibited dopamine uptake but did not alter peak evoked dopamine release. In addition, dopamine release and uptake kinetics in ventral tegmental area slices from dopamine transporter knockout mice were unaltered by the norepinephrine transporter inhibitor, desipramine (10 microM), or the serotonin transporter inhibitor, fluoxetine (10 microM). Furthermore, maximal dopamine release in ventral tegmental area slices from both C57BL/6 and dopamine transporter knockout mice was significantly decreased in response to Na(+) channel blockade by 1 microM tetrototoxin, removal of Ca(2+) from the perfusion media and neuronal vesicular monoamine transporter inhibition by RO-04-1284 (10 microM) or tetrabenazine (10 and 100 microM). Finally, the glutamate receptor antagonists AP-5 (50 and 100 microM) and CNQX (20 and 50 microM) had no effect on peak somatodendritic dopamine release in C57BL/6 mice. Overall, these data suggest that similar mechanisms, consistent with exocytosis, govern electrically evoked dopamine release in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice.
Collapse
Affiliation(s)
- Carrie E John
- Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States
| | | |
Collapse
|
10
|
Yavich L, Jäkälä P, Tanila H. Noradrenaline overflow in mouse dentate gyrus following locus coeruleus and natural stimulation: real-time monitoring by in vivo voltammetry. J Neurochem 2005; 95:641-50. [PMID: 16248883 DOI: 10.1111/j.1471-4159.2005.03390.x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The pattern of catecholaminergic innervation of the dentate gyrus (DG) of the hippocampus, particularly the relatively dense and selective noradrenergic input, creates favourable conditions for real-time monitoring of noradrenaline (NA) release following stimulation of the locus coeruleus (LC) by in vivo voltammetry. Two electrochemically active species with different temporal characteristics were registered in the DG following electrical stimulation of the LC. Several approaches, including testing of anatomical and pharmacological specificity, coating of microelectrodes with Nafion and use of fast cyclic voltammetry, were used to verify the characteristics of electrochemical responses. The first sharp peak that appeared immediately during stimulation was definitely associated with NA overflow. The second late peak was possibly attributable to ascorbic acid. We examined the characteristics of alpha-2 adrenoceptor regulation of NA release in the DG, and showed for the first time that noradrenergic terminals resemble dopaminergic terminals in their mechanisms of increasing the refilling rate of the readily releasable pool following stimulation repeated at short intervals. Amperometric registration of NA in the DG was complicated by interference with electrical activity of hippocampus. This interference could be used, after appropriate filtration, for simultaneous recording from the same microelectrode of NA release and electrical activity of the hippocampus.
Collapse
Affiliation(s)
- Leonid Yavich
- Department of Pharmacology and Toxicology, Universtiy of Kuopio, Kuopio, Finland.
| | | | | |
Collapse
|
11
|
John CE, Budygin EA, Mateo Y, Jones SR. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. J Neurochem 2005; 96:267-82. [PMID: 16300629 DOI: 10.1111/j.1471-4159.2005.03557.x] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
In the present report, fast-scan cyclic voltammetry was used to identify the monoamines that were released by electrical stimulation in mouse brain slices containing ventral tegmental area (VTA), substantia nigra (SN) -pars compacta (SNc) and -pars reticulata (SNr). We showed that voltammograms obtained in mouse VTA were consistent with detection of a catecholamine, while those in both subregions of the SN were consistent with detection of an indolamine, based on the reduction peak potentials. We used pharmacological blockade and genetic deletion of monoamine transporters to further confirm the identity of released monoamines in mouse midbrain and to assess the control of monoamines by their transporters in each brain region. Inhibition of dopamine and norepinephrine transporters by nomifensine (1 and 10 microm) decreased uptake rates in the VTA, but did not change uptake rates in either subregion of the SN. Serotonin transporter inhibition by fluoxetine (10 microm) decreased uptake rates in the SNc and SNr, but was without effect in the VTA. Selective inhibition of the norepinephrine transporter by desipramine (10 microm) had no effect in any brain region. Using dopamine transporter- and serotonin transporter-knockout mice, we found decreased uptake rates in VTA and SN subregions, respectively. Peak signals recorded in each midbrain region were pulse number dependent and exhibited limited frequency dependence. Thus, dopamine is predominately detected by voltammetry in mouse VTA, while serotonin is predominately detected in mouse SNc and SNr. Furthermore, active uptake occurs in these areas and can be altered only by specific uptake inhibitors, suggesting a lack of heterologous uptake. In addition, somatodendritic dopamine release in VTA was not mediated by monoamine transporters. This work offers an initial characterization of voltammetric signals in the midbrain of the mouse and provides insight into the regulation of monoamine neurotransmission in these areas.
Collapse
Affiliation(s)
- Carrie E John
- Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA
| | | | | | | |
Collapse
|
12
|
Grandoso L, Torrecilla M, Pineda J, Ugedo L. α2-Adrenoceptor involvement in the in vitro inhibitory effect of citalopram on a subpopulation of rat locus coeruleus neurons. Eur J Pharmacol 2005; 517:51-8. [PMID: 15975573 DOI: 10.1016/j.ejphar.2005.05.033] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2004] [Revised: 05/18/2005] [Accepted: 05/24/2005] [Indexed: 11/16/2022]
Abstract
The aim of the present study was to investigate the modulation of locus coeruleus neurons by the selective serotonin (5-HT) reuptake inhibitor citalopram using single-unit extracellular recordings in rat brain slices. Citalopram inhibited the activity of a subpopulation of locus coeruleus neurons; thus 10 microM citalopram inhibited neurons by 53+/-17% (5 out of 15 cells), whereas the inhibition due to 100 microM was 64+/-4% (32 out of 42 cells). This effect was partially reversed (47+/-11%) by the alpha(2)-adrenoceptor antagonist idazoxan (10 microM), whereas it was unaffected by antagonists for 5-HT(1A), 5-HT(2,) and 5-HT(3) receptors, and mu opioid receptors. 5-HT (50 or 200 microM), the 5-HT(1A) receptor agonist 8-OH-DPAT (+/-)-8-hydroxy-2-(DI-n-propyl-amino) tetralin hydrobromide, 10 microM) and the 5-HT(2) receptor agonist DOI ([+/-]-2,5-dimetoxy-4-iodoamphetamine) hydrochloride, 10 or 30 microM) also inhibited a subpopulation of locus coeruleus cells. In addition, citalopram but not 5-HT, enhanced by 1.7 fold the inhibitory effect of noradrenaline. Long-term treatment with citalopram (20 mg/kg/day) did not modify the effect of noradrenaline and bromoxidine. Taken together, our results indicate that citalopram exerts an inhibitory effect on locus coeruleus noradrenergic neurons. alpha(2)-adrenoceptor activation may underlie this effect as a result of elevated levels of noradrenaline in the synaptic cleft.
Collapse
Affiliation(s)
- Laura Grandoso
- Departamento de Farmacología, Universidad del País Vasco, E-48940 Leioa, Vizcaya, Spain
| | | | | | | |
Collapse
|
13
|
Fernández-Pastor B, Mateo Y, Gómez-Urquijo S, Javier Meana J. Characterization of noradrenaline release in the locus coeruleus of freely moving awake rats by in vivo microdialysis. Psychopharmacology (Berl) 2005; 180:570-9. [PMID: 15717207 DOI: 10.1007/s00213-005-2181-y] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/13/2004] [Accepted: 01/10/2005] [Indexed: 11/26/2022]
Abstract
RATIONALE The origin and regulation of noradrenaline (NA) in the locus coeruleus (LC) is unknown. OBJECTIVES The neurochemical features of NA overflow (nerve impulse dependence, neurotransmitter synthesis, vesicle storage, reuptake, alpha2-adrenoceptor-mediated regulation) were characterized in the LC. METHODS Brain microdialysis was performed in awake rats. Dialysates were analyzed for NA. RESULTS NA in the LC decreased via local infusion of Ca2+-free medium (-42+/-5%) or the sodium channel blocker tetrodotoxine (TTX) (-47+/-8%) but increased (333+/-40%) via KCl-induced depolarization. The tyrosine hydroxylase (TH) inhibitor alpha-methyl-p-tyrosine (250 mg kg(-1), i.p.) and the vesicle depletory drug reserpine (5 mg kg(-1), i.p.) decreased NA. Therefore, extracellular NA in the LC satisfies the criteria for an impulse flow-dependent vesicular exocytosis of neuronal origin. Local perfusion of the alpha2-adrenoceptor agonist clonidine (0.1-100 microM) decreased NA (E(max)=-79+/-5%) in the LC, whereas the opposite effect (E(max)=268+/-53%) was observed with the alpha2A-adrenoceptor antagonist BRL44408 (0.1-100 microM). This suggests a tonic modulation of NA release through local alpha2A-adrenoceptors. The selective NA reuptake inhibitor desipramine (DMI) (0.1-100 microM) administered into the LC increased NA in the LC (E(max)=223+/-40%) and simultaneously decreased NA in the cingulate cortex, confirming the modulation exerted by NA in the LC on firing activity of noradrenergic cells and on the subsequent NA release in noradrenergic terminals. CONCLUSION Synaptic processes underlying NA release in the LC are similar to those in noradrenergic terminal areas. NA in the LC could represent local somatodendritic release, but also the presence of neurotransmitter release from collateral axon terminals.
Collapse
|
14
|
Pennington JM, Millar J, L Jones CP, Owesson CA, McLaughlin DP, Stamford JA. Simultaneous real-time amperometric measurement of catecholamines and serotonin at carbon fibre 'dident' microelectrodes. J Neurosci Methods 2005; 140:5-13. [PMID: 15589328 DOI: 10.1016/j.jneumeth.2004.03.023] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2003] [Accepted: 03/10/2004] [Indexed: 11/19/2022]
Abstract
Amperometry allows real-time measurement of in vivo electrochemical signals, albeit with no capacity to identify the constituents of the signal. In the present study, differential amperometry was used to monitor catecholamine and serotonin (5-HT) simultaneously at the same location. 'Dident' carbon fibre microelectrodes (microelectrodes with two working electrodes in a single assembly) were constructed and coated with Nafion to prevent poisoning on contact with brain tissue. One electrode (channel A) was held at +200 mV versus Ag/AgCl to monitor catecholamines selectively. This potential is too low to oxidise 5-HT. The second electrode (channel B), recording faradaic current at +500 mV versus Ag/AgCl, measured the sum of catecholamine and 5-HT oxidation. The 5-HT current component was the difference of channel B minus channel A. With appropriate balancing of the two channels, it is possible to record catecholamines and 5-HT simultaneously at the same dident microelectrode. Examples of measurements in striatum, cortex and locus coeruleus are shown.
Collapse
Affiliation(s)
- James M Pennington
- Neurotransmission Laboratory, Academic Department of Anaesthesia and Intensive Care, Barts and the London School of Medicine and Dentistry, Alexandra Wing, Anaesthetic Unit, Royal London Hospital, Whitechapel, London E1 1BB, UK
| | | | | | | | | | | |
Collapse
|
15
|
Invernizzi RW, Garattini S. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:819-27. [PMID: 15363606 DOI: 10.1016/j.pnpbp.2004.05.026] [Citation(s) in RCA: 80] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/10/2004] [Indexed: 11/22/2022]
Abstract
The therapeutic effect of an antidepressant drug takes at least 2 to 3 weeks to develop and a significant proportion of patients have no or only partial benefit regardless of the class of antidepressant used. Research into the neurobiological basis of antidepressant action has suggested new strategies to improve the antidepressant effect. Recent microdialysis studies show that hypofunction of the presynaptic autoreceptors enhances the increase of extracellular serotonin (5-HT) induced by selective serotonin reuptake inhibitors (SSRIs) so it has been suggested that the antidepressant effect may be speeded up by blockade of the autoreceptors. The similarity between the synaptic mechanisms controlling serotonergic and noradrenergic transmission has stimulated preclinical research into the role of presynaptic alpha(2)-adrenoceptors in the effect of noradrenaline (NA) reuptake inhibitors (NRIs) on NA availability at central synapses. The microdialysis studies reviewed here indicate that NRIs including desipramine, reboxetine and atomoxetine, the mixed 5-HT/NA reuptake inhibitors sibutramine, duloxetine, venlafaxine or the NA/DA reuptake inhibitor amineptine, increased extracellular NA in various regions of the rat brain. The effect was enhanced by chronic treatment and even more by the co-administration of alpha(2)-adrenoceptor antagonists. The results support the theory that desensitization of the alpha(2)-adrenoceptor contributes to enhancing the effect of NRIs seen after chronic administration and may account for the slow onset of the antidepressant effect. Finally, they suggest that co-administration of an alpha(2)-adrenoceptor antagonist may improve the therapeutic effect of NRI.
Collapse
Affiliation(s)
- Roberto W Invernizzi
- Istituto di Ricerche Farmacologiche Mario Negri, Via Eritrea 62, 20157 Milano, Italy.
| | | |
Collapse
|
16
|
Hentall ID, Mesigil R, Pinzon A, Noga BR. Temporal and spatial profiles of pontine-evoked monoamine release in the rat's spinal cord. J Neurophysiol 2003; 89:2943-51. [PMID: 12612020 DOI: 10.1152/jn.00608.2002] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
In the spinal cord, the monoamine neurotransmitter norepinephrine, which is released mainly from fibers descending from the dorsal pons, has major modulatory effects on nociception and locomotor rhythms. To map the spatial and temporal patterns of this release, changes in monoamine level were examined in laminae I-VIII of lumbar segments L3-L6 of halothane-anesthetized rats during pontine stimulation. The changes were measured through a carbon fiber microelectrode at 0.5-s intervals by fast cyclic voltammetry, which presently is the method of best spatiotemporal resolution. When different pontine sites were tested with 20-s pulse trains (50-to 200-microA amplitude, 0.5-ms pulse width, and 50-Hz frequency) during measurement in the dorsal horn (lamina IV), the largest consistent increases were produced by the locus ceruleus, although effective pontine sites extended 1.5 mm dorsally and ventral from the locus ceruleus. When the locus ceruleus stimulus was used to map the spinal cord, increased levels were always seen in lamina I and laminae IV-VIII, whereas 50% of sites in laminae II and III showed substantial decreases and the rest showed increases. These increases typically had short latencies [4.5 +/- 0.4 (SE) s] and variable decay times (5-200 s), with peaks occurring during the stimulus train (mean rise-time: 12.0 +/- 0.6 s). The mean peak level was 544 +/- 82 nM as estimated from postexperimental calibration with norepinephrine. Other significant laminar differences included higher mean peak concentrations (805 nM) and rise times (14.9 s) in lamina I and shorter latencies in lamina VI (3.2 s). Peak concentrations were inversely correlated with latency. When stimulation frequency was varied, increases were disproportionately larger with faster frequencies (> or =50 Hz), hence extrajunctional overflow probably contributed most of the signal. We conclude, generally, that pontine noradrenergic control is exerted on widespread spinal laminae with a significant component of paracrine transmission after several seconds of sustained activity. Relatively stronger effects prevail where nociceptive transmission (lamina I) and locomotor rhythm generation (lamina VI) occur.
Collapse
Affiliation(s)
- Ian D Hentall
- Department of Biomedical Sciences,University of Illinois College of medicine, Rockford, 311007-1897, USA
| | | | | | | |
Collapse
|
17
|
Owesson CA, Hopwood SE, Callado LF, Seif I, McLaughlin DP, Stamford JA. Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice. Eur J Neurosci 2002; 15:1516-22. [PMID: 12028362 DOI: 10.1046/j.1460-9568.2002.01986.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Monoamine oxidase-A knockout (MAO-A KO) mice have elevated brain serotonin (5-HT) and noradrenaline (NA) levels, and one would therefore anticipate increased monoamine release and compensatory changes in other aspects of presynaptic monoamine function. In this study we used voltammetry in brain slices from the locus coeruleus (LC), dorsal raphe (DRN) and striatum (CPu) in 7-week-old MAO-A KO and C3H control mice to measure stimulated monoamine efflux and its control by amine transporters and autoreceptors. In LC, peak NA efflux on stimulation (99 pulses, 100 Hz) was higher in MAO-A KO than C3H mice (938 +/- 58 nm cf. 511 +/- 42 nm; P < 0.001). The NA uptake half time (t(1/2)) was longer in MAO-A KO than in C3H mice (6.0 +/- 0.9 s cf. 1.9 +/- 0.3 s; P < 0.001) and the selective NA reuptake inhibitor desipramine (50 nm) had a smaller effect in MAO-A KO mice. NA transporter binding was significantly lower in the LC of MAO-A KO mice compared to C3H controls (P < 0.01) but not in the DRN. The alpha 2 agonist dexmedetomidine (10 nm) decreased stimulated NA efflux more in C3H than in MAO-A KO mice (73.3% cf. 29.6% inhibition, P < 0.001). In DRN, peak 5-HT efflux on stimulation (99 pulses, 100 Hz) was greater (P < 0.01) in MAO-A KO (262 +/- 44 nm) than C3H mice (157 +/- 16 nm). Moreover, 5-HT uptake t(1/2) was longer (P < 0.05) in MAO-A KO than in C3H mice (8.8 +/- 1.1 s cf. 4.9 +/- 0.6 s, P < 0.05) and the effect of citalopram (75 nm) was attenuated in MAO-A KOs. Serotonin transporter binding was also lower in both the DRN and LC of MAO-A KO mice. The 5-HT(1A) agonist 8-OH-DPAT (1 microm) decreased 5-HT efflux more in C3H than in MAO-A KO mice (38.3% inhibition cf. 21.6%, P < 0.001). In contrast, there were no significant differences between MAO-A KO and C3H mice in CPu dopamine efflux and uptake and the effect of the D(2/3) agonist quinpirole was similar in the two strains. In summary, MAO-A KO mice show major dysregulation of monoaminergic presynaptic mechanisms such as autoreceptor control and transporter kinetics.
Collapse
Affiliation(s)
- Catarina A Owesson
- Neurotransmission Laboratory, Academic Department of Anaesthesia and Intensive Care, Barts and The London School of Medicine and Dentistry, Alexandra Wing, Royal London Hospital, Whitechapel, London E1 1BB, UK
| | | | | | | | | | | |
Collapse
|
18
|
Hopwood SE, Stamford JA. Noradrenergic modulation of serotonin release in rat dorsal and median raphé nuclei via alpha(1) and alpha(2A) adrenoceptors. Neuropharmacology 2001; 41:433-42. [PMID: 11543763 DOI: 10.1016/s0028-3908(01)00087-9] [Citation(s) in RCA: 57] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The rat rostral raphé nuclei receive catecholaminergic innervation from the locus coeruleus and other areas. In the present study, we investigated noradrenergic modulation of 5-HT release in rat dorsal and median raphé nuclei (DRN and MRN) slices (350 microm thick) superfused with artificial cerebrospinal fluid (aCSF). The raphé was locally stimulated (0.1 ms pulses, 10 mA) and 5-HT release was monitored at carbon fibre microelectrodes using fast cyclic voltammetry. The selective noradrenaline reuptake inhibitor desipramine (50 nM) did not increase stimulated (20 pulses, 100 Hz) 5-HT release but significantly slowed 5-HT reuptake in both DRN and MRN. On short stimulus trains (10 pulses, 200 Hz), the alpha(2)-selective agonist dexmedetomidine (10nM) decreased evoked 5-HT release in DRN and MRN (to 44+/-3 and 43+/-7% of pre-drug values, respectively, at minimum). In both nuclei, this response was antagonised by the selective alpha(2A)-antagonist BRL 44408 (1 microM: P<0.001 vs. dexmedetomidine) but not by the selective alpha(2B/C)-adrenoceptor antagonist ARC 239 (500 nM), the selective 5-HT(1A) antagonist WAY 100635 (100 nM) or the alpha(1)-selective antagonist prazosin (1 microM), suggesting that the effect of dexmedetomidine is wholly attributable to alpha(2A)-receptor activation. The alpha(1)-adrenoceptor agonist phenylephrine (5 microM) significantly decreased 5-HT release (to 49+/-7 and 41+/-4% of pre-drug values in DRN and MRN, respectively). The response was blocked by prazosin (P<0.001) and BRL 44408 (P<0.01) in DRN and by prazosin, BRL 44408 and WAY 100635 (all P<0.05) in MRN, suggesting that the effect of phenylephrine is, under these conditions, only partly mediated via alpha(1)-adrenoceptors. On long stimuli (30 pulses, 10 Hz), BRL 44408 (1 microM) increased evoked 5-HT efflux to 187+/-17 and 178+/-2% of pre-drug values in DRN and MRN, respectively (both P<0.001 vs. vehicle). Collectively, these data show that activation of both alpha(1) and alpha(2A)-adrenoceptors can decrease stimulated 5-HT release in the rostral raphé nuclei. Since the effect of dexmedetomidine was not antagonised by prazosin, we suggest that its effect was mediated directly, possibly through alpha(2A) receptors located on 5-HT cell elements, and not transduced indirectly through alpha(1)-adrenoceptor activation, as previously suggested by others.
Collapse
Affiliation(s)
- S E Hopwood
- Neurotransmission Laboratory, Academic Department of Anaesthesia and Intensive Care, St Bartholomew's and The Royal London School of Medicine and Dentistry, Alexandra Wing, Royal London Hospital, Whitechapel, London E1 1BB, UK
| | | |
Collapse
|
19
|
Mateo Y, Ruiz-Ortega JA, Pineda J, Ugedo L, Meana JJ. Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmission in vivo. Neuropharmacology 2000; 39:2036-43. [PMID: 10963747 DOI: 10.1016/s0028-3908(00)00041-1] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The in vivo effect of the serotonin (5-HT) reuptake inhibitor antidepressant citalopram, administered in the locus coeruleus (LC), on noradrenergic transmission was evaluated in the rat brain. In dual-probe microdialysis assays, citalopram (0.1-100 microM), in a concentration-dependent manner, increased extracellular noradrenaline (NA) in the LC and simultaneously decreased extracellular NA in the cingulate cortex (Cg). These effects of citalopram were abolished by pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (400 mg/kg, i.p.). When the alpha(2)-adrenoceptor antagonist RS79948 (1 microM) was perfused in the LC, local citalopram increased NA dialysate in the LC but no longer modified NA dialysate in the Cg. In electrophysiological experiments, the administration of citalopram (100 microM) in the LC by reversal dialysis, decreased the firing rate of LC neurones. The results demonstrate in vivo that local administration of citalopram in the LC leads to a decreased release of NA in the Cg. This modulation seems to be the result of an increase in NA concentration in the LC and the subsequent inhibition of LC neurones via alpha(2)-adrenoceptors. The effects of citalopram are dependent on the presence of endogenous 5-HT in the LC.
Collapse
Affiliation(s)
- Y Mateo
- Department of Pharmacology, University of the Basque Country, E-48940 Leioa, Bizkaia, Spain
| | | | | | | | | |
Collapse
|
20
|
Davidson C, Ellinwood EH, Douglas SB, Lee TH. Effect of cocaine, nomifensine, GBR 12909 and WIN 35428 on carbon fiber microelectrode sensitivity for voltammetric recording of dopamine. J Neurosci Methods 2000; 101:75-83. [PMID: 10967364 DOI: 10.1016/s0165-0270(00)00264-8] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Electrochemical measurements using voltammetry or amperometry at carbon-fiber microelectrodes have been used in vitro and in vivo to examine regulatory mechanisms for the central dopamine system. In many of these experiments, dopamine efflux concentrations under control conditions are determined followed by their alterations in response to a drug treatment. The present study demonstrates that some drugs can affect dopamine measurements, not only by their expected pharmacological action but also by directly altering the microelectrode responsivity. The commonly used reuptake inhibitors GBR 12909 (10 microM) and nomifensine (5 microM) drastically reduce electrode sensitivity and, in the case of nomifensine, increase the time to reach a plateau in response to dopamine boluses (i.e. reduced 'frequency response'). Cocaine (10 microM) and WIN 35428 (2 microM) have negligible effect on these indices. This decrease in sensitivity was found in both nafion and non-nafion coated electrodes. Further, the reduction in sensitivity seen in non-nafion coated electrodes was not prevented by increasing the reversal potential (from +1.0 to +1.3 V) and voltage scan rate (from 350 to 450 V/s). These data suggest that care must be taken when interpreting data from voltammetric or amporometric experiments using carbon electrodes where GBR 12909 or nomifensine are used, especially at high concentrations. Furthermore, wherever possible, direct effects of a drug on electrode sensitivity and frequency response should be determined.
Collapse
Affiliation(s)
- C Davidson
- Department of Psychiatry, Box 3870, Duke University Medical Center, Durham, NC 27710, USA.
| | | | | | | |
Collapse
|
21
|
Callado LF, Stamford JA. Spatiotemporal interaction of alpha(2) autoreceptors and noradrenaline transporters in the rat locus coeruleus: implications for volume transmission. J Neurochem 2000; 74:2350-8. [PMID: 10820195 DOI: 10.1046/j.1471-4159.2000.0742350.x] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
We investigated the roles of alpha(2) autoreceptors and noradrenaline (NA) transporters on NA efflux and uptake in the rat locus coeruleus after electrical stimulation. NA efflux was evoked by various trains (50 pulses, 10-500 Hz) and measured by fast cyclic voltammetry. NA efflux and uptake half-time (t(1/2)) were stimulus-dependent, ranging from 43 +/- 3 nM and 2.45 +/- 0.21 s, respectively, with 500-Hz stimuli to 127 +/- 11 nM and 4.41 +/- 0.34 s, respectively, with 100-Hz trains. Based on these data, we calculate that each transporter removes 0.19 NA molecules from the extracellular space every second, a velocity compatible more with transporter-than channel-mode conduction. Dexmedetomidine (10 nM) decreased NA efflux by approximately 30% on stimulations of < or =1 s in duration. BRL 44408 (1 microM) increased NA efflux on stimuli of > or =2 s (by up to 92 +/- 16%). Desipramine (50 nM) increased NA efflux on stimuli of > or =1 s (by 113 +/- 24%) but slowed NA uptake on all stimuli. When given together, the effects of desipramine and BRL 44408 were additive at stimuli of >or =1 s but showed potentiation on shorter trains. There was a significant time delay for the elevation of NA efflux by blockade of uptake (0.79 s) or autoreceptors (1.14 s), suggesting that both are located extrasynaptically and that NA must diffuse through the extracellular space to these structures. We suggest that released NA may interact with alpha(2) autoreceptors and NA transporters as far as 10 microm from the release sites, an action compatible with a volume transmission role of NA in the locus coeruleus.
Collapse
Affiliation(s)
- L F Callado
- Neurotransmission Laboratory, Academic Department of Anaesthesia and Intensive Care, St. Bartholomew's and Royal London School of Medicine and Dentistry, Royal London Hospital, London, England
| | | |
Collapse
|
22
|
Callado LF, Hopwood SE, Hancock PJ, Stamford JA. Effects of dizocilpine (MK 801) on noradrenaline, serotonin and dopamine release and uptake. Neuroreport 2000; 11:173-6. [PMID: 10683852 DOI: 10.1097/00001756-200001170-00034] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
In the present study, we examined the actions of the NMDA antagonist dizocilpine (MK801) on electrically evoked release and uptake of noradrenaline (NA) in the locus coeruleus (LC), serotonin (5-HT) in the dorsal raphe nucleus (DRN) and dopamine (DA) in the nucleus accumbens (NAc), measured by fast cyclic voltammetry (FCV) in rat brain slices. Dizocilpine (10 microM) significantly increased NA (to 248 +/- 15%) and 5-HT release (to 184 +/- 29%) and slowed monoamine uptake in the LC (t1/2 = 853 +/- 129%) and the DRN (t1/2 = 387 +/- 70%), respectively. However, dizocilpine had no effect on DA release or uptake in NAc. Actions on monoamines are thus likely and should be considered in the interpretation of data regarding dizocilpine.
Collapse
Affiliation(s)
- L F Callado
- Academic Department of Anaesthesia and Intensive Care, St Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital, UK
| | | | | | | |
Collapse
|
23
|
Callado LF, Stamford JA. Alpha2A- but not alpha2B/C-adrenoceptors modulate noradrenaline release in rat locus coeruleus: voltammetric data. Eur J Pharmacol 1999; 366:35-9. [PMID: 10064149 DOI: 10.1016/s0014-2999(98)00889-9] [Citation(s) in RCA: 76] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
In this study, we used subtype-selective antagonists to determine the subtype of alpha2-adrenoceptor controlling noradrenaline release in rat locus coeruleus. Noradrenaline release was measured in locus coeruleus slices using fast cyclic voltammetry at carbon fibre microelectrodes. On long stimulation trains (40 pulses, 20 Hz), the alpha2A-adrenoceptor selective antagonist BRL 44408 (2-[2H-(1-methyl-1,3-dihydroisoindole) methyl]-4,5-dihydroimidazole) at 100 nM and 1 microM significantly increased stimulated noradrenaline release, whereas the alpha2B/C-selective antagonist ARC 239 (2-[2[4-(o-methoxyphenyl)piperazin-1-yl] ethyl]-4,4dimethyl-1,3-(2H,4H)-isoquinolinedione) at 50 and 500 nM had no effect. On short stimuli (20 pulses, 200 Hz), the non-specific alpha2-adrenoceptor agonist dexmedetomidine (10 nM) significantly decreased noradrenaline release, an effect reversed by BRL 44408 (1 microM) but not by ARC 239 (500 nM). These data demonstrate that autoreceptor control of noradrenaline release in the locus coeruleus is mediated by alpha2A but not alpha2B/C-adrenoceptors.
Collapse
Affiliation(s)
- L F Callado
- Academic Department of Anaesthesia and Intensive Care, St. Bartholomew's and the Royal London School of Medicine and Dentistry, Royal London Hospital, Whitechapel, UK
| | | |
Collapse
|
24
|
Van Bockstaele EJ. Morphological substrates underlying opioid, epinephrine and gamma-aminobutyric acid inhibitory actions in the rat locus coeruleus. Brain Res Bull 1998; 47:1-15. [PMID: 9766384 DOI: 10.1016/s0361-9230(98)00062-8] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
The locus coeruleus (LC) has been implicated in attentional processes related to orienting behaviors, learning and memory, anxiety, stress, the sleep-wake cycle, and autonomic control, as well as to contributing to the affective state. Direct activation of LC neurons causes desynchronization of the electroencephalogram, suggesting that the LC is an important modulator of the behavioral state. The LC has been an intensely studied neuronal system, as the physiology and pharmacology of this nucleus is well understood. This is mainly because of the similarity in neurochemical composition of LC cells which all contain norepinephrine in the rat. However, the homogeneity in neurotransmitter content in LC neurons is sharply contrasted by the heterogeneity of neurochemicals found in its afferent processes. Among these are axon terminals that contain inhibitory and excitatory amino acids, monoamines, and neuropeptides, many of which have been shown to exert differential physiological effects on LC discharge activity. Although much attention has focused on physiological activation of LC neurons, substantial evidence indicates that diverse afferents prominently inhibit noradrenergic cellular activity. Such inhibitory neurochemicals, which arise from local and extrinsic sources, include gamma-aminobutyric acid (GABA) and epinephrine as well as the neuropeptides methionine5-enkephalin and leucine5-enkephalin. Inhibitory transmission in the LC has widespread implications for norepinephrine release at diverse postsynaptic targets, and clinically useful pharmacological agents such as clonidine, an alpha2 adrenergic receptor agonist that potently inhibits the firing of LC neurons, alleviate some negative physical symptoms observed following withdrawal from opiates. In the present review, the synaptic and functional organization of selected inhibitory-type neurotransmitters in the LC obtained from immunoelectron microscopic data will be discussed.
Collapse
Affiliation(s)
- E J Van Bockstaele
- Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA 19107, USA.
| |
Collapse
|
25
|
Shinba T, Andow Y, Shinozaki T, Ozawa N, Yamamoto K. Phasic increase of monoamine-related electrochemical signal in the rat caudate nucleus following conditioned auditory stimulation during the reaction-time task. Brain Res 1998; 781:284-90. [PMID: 9507165 DOI: 10.1016/s0006-8993(97)01254-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Monoamine-related electrochemical signal was measured by in vivo chronoamperometry at a sampling rate of 5 Hz with a Nafion-coated carbon fiber placed in the caudate nucleus of the rat (n=5) performing an auditory reaction-time task. During the task, the rat pressed a lever in response to a tone stimulus to get food reward. An averaging technique was employed to extract event-related changes in monoamine concentration with respect to the tone stimulus, lever pressing or feeding. It was found that the oxidation current increased phasically for several seconds following the tone presentation with the mean onset latency being 0.4+/-0.2 s. Lever pressing was preceded by the onset of increase in two rats. Prominent increase was not observed following the tone presentation during the resting state, passive feeding, and lever pressing unrelated to the task. The results indicate that phasic increase in monoamine concentration occurs at the caudate nucleus in response to conditioned auditory stimulation in the reaction-time task. This response is not simply the consequence of sensory stimulation, motor reaction, or feeding, but is possibly influenced by integrative processes. The present electrochemical findings are consistent with the previous electrophysiological data on dopamine neuronal activity. However, pharmacological researches will be necessary in order to determine the substance involved in the phasic response.
Collapse
Affiliation(s)
- T Shinba
- Department of Neurophysiology, Tokyo Institute of Psychiatry, 2-1-8 Kamikitazawa, Setagaya-ku, Tokyo 156, Japan.
| | | | | | | | | |
Collapse
|
26
|
Vachette C, Nowak LG, Amouretti X, Renaud B, Bullier J. In vitro study of the catecholaminergic metabolism of locus coeruleus neurones by differential normal pulse voltammetry. J Neurosci Methods 1995; 63:103-12. [PMID: 8788054 DOI: 10.1016/0165-0270(95)00093-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
The aim of the present work was to measure, by voltammetry, the catecholaminergic metabolic activity of rat locus coeruleus (LC) neurones in brain slices. For this new experimental approach, we used an optimized protocol of slice preparation intended to prevent neuronal damages due to brain ischaemia. Our results show that the LC neurones exhibit in vitro a stable spontaneous catecholaminergic metabolic activity and that, as in vivo, 3,4-dihydroxyphenylacetic acid (DOPAC) is likely to be the main contributor to the recorded signal. This catecholaminergic metabolic activity can be pharmacologically altered by administering carbachol and clonidine to the superfusion fluid. We also determined the values of bath temperature and superfusion flow rate providing, in our methodological conditions, an optimal catecholaminergic metabolic activity. Finally, we took advantage of both the direct accessibility to the LC and the compactness of this nucleus to determine the spatial resolution of differential normal pulse voltammetry. In conclusion, the study of the subregional mechanisms controling the catecholaminergic metabolism in LC neurones can be performed in brain slices by differential normal pulse voltammetry.
Collapse
Affiliation(s)
- C Vachette
- Laboratoire de Neuropharmacologie, Université Claude Bernard and CNRS UMR 105, Lyon, France
| | | | | | | | | |
Collapse
|